CATALIS Begins Its Public And Patient Engagement Process Since last summer, CATALIS has been developing a patient component that will also complement the comprehensive, collaborative model that defines the organization’s mission. This model already has a wide range of life sciences industry stakeholders, such as the Ministry of Economy and Innovation, the Ministry of Health and Social Services, CATALIS network
The CATALIS Public-Private Network has developed a new FAST TRACK evaluation service that will eventually allow industry-funded clinical trials to be authorized in less than 8 weeks.
CATALIS is hiring! TITLE: Project Manager – Clinical Trials LOCATION: Montreal, QC INDUSTRY: NPO, Clinical trials Permanent position, full time SUMMARY OF THE POSITION Under the authority of the Director General, the Project Manager collaborates in activities related to the accelerated evaluation service for clinical trials in Quebec; and other operational activities of CATALIS. MAIN RESPONSIBILITIES • Assists the Managing
CATALIS is hiring! We are looking for a professional in communications inspired to develop promotional campaigns to inform the clinical research network. Under the authority of the CEO, the Senior Communications Advisor will participate in the development, implementation and monitoring of the organization’s communications and marketing activities. MAIN RESPONSIBILITIES • Develop, implement and monitor the organization’s communication and marketing activities:
CATALIS is launching a new call for applications to select public institutions that will receive 2 years of funding for their participation in CATALIS activities. Within the call for applications, public institutions that are members of the Table nationale des directeurs de recherche (TNDR) are invited to apply on 2 levels of clinical research activities: the implementation of automated tools
CATALIS is now implementing its new strategic plan with the creation of new advisory committees Since 2018, CATALIS’s operational activities have been guided essentially by an advisory committee composed of research centre administrators, pharmaceutical industry members, and government representatives. In 2021, given that the new strategic plan extends the scope of CATALIS’s actions, two new advisory committees will be created: a
CATALIS has great plans for the coming year. A message from the chairman of the CATALIS board of directors, Dr. Marc Rivière There is no doubt that this past year has been disconcerting and most unusual. Clinical research was confronted with substantial challenges that highlighted our system’s ability to adapt quickly and find innovative solutions. This exceptional situation caused us to
Boehringer Ingelheim and Sanofi Join the CATALIS Network New pharmaceutical industry partners are supporting CATALIS in making Quebec a world leader in clinical research. MONTREAL, May 20, 2021 —CATALIS Québec is proud to announce that two pharmaceutical companies, Boehringer Ingelheim and Sanofi, have joined its network of partners who are working together to support Quebec’s competitiveness in conducting clinical trials.
Diffusion of the updated “Standard legal clauses for information and consent forms for clinical trials” CATALIS Québec is pleased to announce that the revised version of the “Standard legal clauses for information and consent forms for clinical trials” has been published by the ministry of health and social services (MSSS). The original legal clauses for consent forms, published in 2016
CATALIS Quebec announces the rolls out the 2nd phase of Nagano clinical trial evaluation management system synchronization in the Quebec’s health and social services institutions Since 2010, majority of public institutions in Quebec’s health and social services network have gradually integrated the Nagano computer system, a platform that makes the administrative management of research projects, including clinical trials’ evaluation and